NR 4-6/2006

get MSIE 4.x or better from www.microsoft.com/ie

Zastosowanie terapii fotodynamicznej w leczeniu ograniczonych naczyniaków naczyniówki

Photodynamic therapy of circumscribed choroidal hemangioma

Agnieszka Kubicka-Trz±ska, Bożena Romanowska-Dixon

Z Katedry i Kliniki Okulistyki Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie
Kierownik: dr hab. n. med. Bożena Romanowska-Dixon

Summary: Purpose: To evaluate efficacy of photodynamic therapy (PDT) with verteporfin in treatment of posterior pole symptomatic circumscribed choroidal hemangiomas.
Material and methods: Four patients (3 men and 1 woman), 15-55 years old (mean age: 29 years) with circumscribed choroidal hemangiomas of the posterior pole, were examined. The hemangiomas localization were subfoveal in one patient, extrafoveal in 2 cases, and juxtapapillar in one case. The diagnosis of choroidal hemangioma was established on the base of clinical examination, A and B – scan ultrasound imaging, Doppler ultrasonography, fluorescein and indocyanine angiography results. Tumour thickness before treatment ranged from 2.3-3.6 mm (mean thickness: 2.8 mm). One course of PDT with verteporfin was performed in 3 cases, while in one patient PDT was performed four times.
Results: In a follow-up period which range from 3 to 14 months (mean 5.7 months) all cases demonstrated clinical features of lesion regression with a reduction of thickness on ultrasonography and choroidal vasculature on angiograms. Visual acuity was improved in 3 patients (from 1 to 4 lines on Snellen charts), or remained stable in 1 case.
Conclusions: Our preliminary results indicate that PDT with verteporfin is a safe and effective method of treatment for circumscribed choroidal hemangiomas, especially in patients with posterior pole location of the tumour.
Słowa kluczowe:  ograniczony naczyniak naczyniówki, terapia fotodynamiczna.
Key words: circumscribed choroidal haemangiona, photodynamic therapy.



linia-lewa.gif (150 bytes)


Wydawca dwumiesięcznika medycznego "Klinika Oczna"
Oftal Sp. z o.o.

ul. Lindleya4, 02-005 Warszawa
Oddział: 03-709 Warszawa ul. Sierakowskiego 13 (Szpital)

tel./fax: (0-22) 670-47-40
centrala: (0-22) 618-84-85 wew. 52-45

e-mail: ored@okulistyka.com.pl